ReviewPharmaceutical salts: A summary on doses of salt formers from the Orange Book

Add time:09/02/2019    Source:sciencedirect.com

Over half of the active pharmaceutical ingredients currently approved within the US are pharmaceutical salts. Selection of suitable pharmaceutical salts is carried out during late research or early development phase. Therefore several properties of different pharmaceutical salts of a new chemical entity are assessed during salt screening and salt selection. This typically includes physico-chemical behavior, dissolution rate and pharmacokinetics of a pharmaceutical salt. Beyond these properties also toxicological aspects have to be taken into account. As a starting point for a toxicological assessment we present an overview of the usage of pharmaceutical salts as described in the FDA’s Orange Book including maximum daily doses for the most important administration routes.

We also recommend Trading Suppliers and Manufacturers of ETHYLENEDIAMINETETRAACETIC ACID DICALCIUM SALT (cas 19709-85-4). Pls Click Website Link as below: cas 19709-85-4 suppliers

Prev:Original articleProliferation and gene expression of osteoblasts cultured in DMEM containing the ionic products of dicalcium silicate coating☆
Next:Original ResearchDiet-induced obesity and weight loss alter bile acid concentrations and bile acid–sensitive gene expression in insulin target tissues of C57BL/6J mice)